These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 31055643)

  • 1. Biological functions of mesenchymal stem cells and clinical implications.
    Naji A; Eitoku M; Favier B; Deschaseaux F; Rouas-Freiss N; Suganuma N
    Cell Mol Life Sci; 2019 Sep; 76(17):3323-3348. PubMed ID: 31055643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
    Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A
    Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.
    Du WJ; Chi Y; Yang ZX; Li ZJ; Cui JJ; Song BQ; Li X; Yang SG; Han ZB; Han ZC
    Stem Cell Res Ther; 2016 Nov; 7(1):163. PubMed ID: 27832825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.
    Xu L; Liu Y; Sun Y; Wang B; Xiong Y; Lin W; Wei Q; Wang H; He W; Wang B; Li G
    Stem Cell Res Ther; 2017 Dec; 8(1):275. PubMed ID: 29208029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.
    Mao F; Tu Q; Wang L; Chu F; Li X; Li HS; Xu W
    Oncotarget; 2017 Jun; 8(23):38008-38021. PubMed ID: 28402942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
    Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
    Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.
    Holan V; Palacka K; Hermankova B
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis.
    Manzini BM; da Silva Santos Duarte A; Sankaramanivel S; Ramos AL; Latuf-Filho P; Escanhoela C; Kharmandayan P; Olalla Saad ST; Boin I; Malheiros Luzo ÂC
    Cytotherapy; 2015 Aug; 17(8):1052-65. PubMed ID: 26139545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells.
    Mennan C; Garcia J; Roberts S; Hulme C; Wright K
    Stem Cell Res Ther; 2019 Mar; 10(1):99. PubMed ID: 30885254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the heterogeneity and functional diversity of human mesenchymal stem cells.
    Han ZC; Du WJ; Han ZB; Liang L
    Biomed Mater Eng; 2017; 28(s1):S29-S45. PubMed ID: 28372276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
    Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
    Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.
    Rebelatto CK; Aguiar AM; Moretão MP; Senegaglia AC; Hansen P; Barchiki F; Oliveira J; Martins J; Kuligovski C; Mansur F; Christofis A; Amaral VF; Brofman PS; Goldenberg S; Nakao LS; Correa A
    Exp Biol Med (Maywood); 2008 Jul; 233(7):901-13. PubMed ID: 18445775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current basic understanding and clinical application of mesenchymal stromal/stem cells].
    Miura Y
    Rinsho Ketsueki; 2018; 59(10):1935-1941. PubMed ID: 30305494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy.
    Montespan F; Deschaseaux F; Sensébé L; Carosella ED; Rouas-Freiss N
    J Immunol Res; 2014; 2014():230346. PubMed ID: 24877156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
    Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
    Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy.
    Jin HJ; Bae YK; Kim M; Kwon SJ; Jeon HB; Choi SJ; Kim SW; Yang YS; Oh W; Chang JW
    Int J Mol Sci; 2013 Sep; 14(9):17986-8001. PubMed ID: 24005862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.